Shanghai Tongji Hospital of Tongji University

CART Treatment Team in Tongji Hospital of
Tongji University

Nursing Team

Advantages of Hematology Department in Tongji Hospital of Tongji University

Rich experience leading in China

Multidisciplinary escort

Whole Process Treatment Management

Individualized treatment of difficult cases

Extensive experience-
1000 + clinical CAR-T treatment cases

1000 + Treatment Experience

Developed sensitivity, rapid response, close collaboration

Various CAR-T issues handled

Developed a mature CAR-T treatment paradigm

Subject Leader-Professor Aibin Liang

Aibin Liang

Vice President, Director of Hematology Department, Doctoral Tutor, Professor, Tongji Hospital of Tongji University

Deputy Secretary-General, Experimental Hematology Committee, Chinese Society of Pathophysiology
Vice Chairman, Professional Committee of Tumor Targeted Therapy, Chinese Anticancer Association
Vice Chairman, Professional Committee of Biotherapeutics in China Research Hospitals
Member of Hematology Branch of Chinese Medical Association
National Standing Committee of Chinese Medical Association
Chairman of Hematology Branch of Shanghai Medical Association
Vice President of Hematology Branch of Shanghai Physicians Association
Vice Chairman of Hematology Branch of Shanghai Anti-Cancer Association
Vice Chairman, Professional Committee of Hematological Immunology, Shanghai Society of Immunology
Young and middle-aged experts with outstanding contributions at the national level and enjoy special allowances from the State Council
National Candidates for "Hundreds of Million Talents Project"
2020 Saint-Antoine-EBMT young leader; 4th title of “National famous doctor, excellent style”; model dean of stroke prevention and treatment project of the National Health Commission of 2019; Scientific Chinese Person of the Year 2018; Ministry of Education “Excellent Talents in the New Century”; 2012 “Excellent Workers of the National Health System”; Shanghai Excellent Subject Leader, “Science and Technology Star”; “Silver Snake Award” Second Prize and “Dawn Scholar”.

Case Study

Equecabtagene helped overseas patients to achieve deep remission. CR was sustained 3 months after reinfusion, and extramedullary masses subsided.

Learn More

Request a Consultation Now for Car-t Programs for Multiple Myeloma

*Required

First name *

Last name *

Email address *

Phone number *

Uploading Case Information：

Upload case photos for expert advice

Maximum 6 images，3Mb each picture limited

Additional Information:

*By providing this information, you are granting Car-T Service and companies working with Car-T Service permission to contact you about this and future opportunities.